Keywords: bayer, files, eu, moxifloxacin, filed, approval, europe

Bayer Files In EU For Moxifloxacin

Article | 02 December 1998

Bayer has filed for approval in Europe for its new-generation quinoloneantibiotic, moxifloxacin (BAY 12-8039), in community-acquired infections. The license has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bayer

Go to company listing

Related Drugs

Moxifloxacin

Vigamox

Aspirin

Bayer

Go to drug listing